Literature DB >> 30654391

Extracellular Vesicles in Liver Diseases: Diagnostic, Prognostic, and Therapeutic Application.

Sabine K Urban1, Tudor Mocan2, Hanna Sänger1, Veronika Lukacs-Kornek3, Miroslaw Kornek4,5.   

Abstract

Extracellular vesicles, comprising exosomes, microvesicles, and apoptotic bodies, represent an emerging field in disease diagnostics and prognosis. They can be isolated from peripheral blood of patients as well as from other body fluids and can therefore be considered a minimally invasive liquid biopsy screening tool. Especially their surface antigen composition can reveal information about disease backgrounds. For several liver diseases, including fatal hepatocellular and cholangiocellular carcinoma as well as other nonmalignant liver disorders such as nonalcoholic fatty liver disease, alcoholic hepatitis, or acute liver failure, it has been shown that extracellular vesicle (EV) surface profiling can be useful for disease diagnosis and prognosis. This review focuses on latest advances in these areas to improve liver disorder detection and management. Additionally, the authors will discuss possible therapeutic applications of EVs in liver diseases, which might be a potent treatment option in the future. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30654391     DOI: 10.1055/s-0038-1676122

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  15 in total

1.  Extracellular vesicles small RNA clusters: hit the nail on the head of liver cancer detection.

Authors:  Artur Słomka; Bingduo Wang; Tudor Mocan; Maria González-Carmona; Christian P Strassburg; Veronika Lukacs-Kornek; Miroslaw T Kornek
Journal:  Hepatobiliary Surg Nutr       Date:  2022-02       Impact factor: 7.293

Review 2.  Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease.

Authors:  Dongqing Wu; Huaqing Zhu; Hua Wang
Journal:  Front Physiol       Date:  2021-07-14       Impact factor: 4.566

Review 3.  Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.

Authors:  Rolf Teschke; Jack Uetrecht
Journal:  Ann Transl Med       Date:  2021-04

Review 4.  Cardiomyocyte-Derived Exosomes: Biological Functions and Potential Therapeutic Implications.

Authors:  Hui Yu; Zhanli Wang
Journal:  Front Physiol       Date:  2019-08-20       Impact factor: 4.566

Review 5.  Extracellular Vesicles as Inflammatory Drivers in NAFLD.

Authors:  Akshatha N Srinivas; Diwakar Suresh; Prasanna K Santhekadur; Deepak Suvarna; Divya P Kumar
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

Review 6.  Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?

Authors:  Filippo Pelizzaro; Romilda Cardin; Barbara Penzo; Elisa Pinto; Alessandro Vitale; Umberto Cillo; Francesco Paolo Russo; Fabio Farinati
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

7.  miRNA and long non-coding RNA transcriptional expression in hepatocellular carcinoma cell line-secreted extracellular vesicles.

Authors:  Manuela Cabiati; Costanza Salvadori; Giuseppina Basta; Serena Del Turco; Paolo Aretini; Antonella Cecchettini; Silvia Del Ry
Journal:  Clin Exp Med       Date:  2021-07-28       Impact factor: 3.984

Review 8.  Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy.

Authors:  Alejandra Hernández; Juan Pablo Arab; Daniela Reyes; Ainhoa Lapitz; Han Moshage; Jesús M Bañales; Marco Arrese
Journal:  Cells       Date:  2020-03-27       Impact factor: 6.600

Review 9.  Extracellular Vesicles, A Possible Theranostic Platform Strategy for Hepatocellular Carcinoma-An Overview.

Authors:  Igea D'Agnano; Anna Concetta Berardi
Journal:  Cancers (Basel)       Date:  2020-01-21       Impact factor: 6.639

Review 10.  Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases.

Authors:  Seonghwan Hwang; Yoon Mee Yang
Journal:  Arch Pharm Res       Date:  2021-06-24       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.